Radiopharm Theranostics Ltd (RADX) income statement
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
$0.63−0.04 (-6.33%)
Close on Nov 20, 2026Market cap $7.45MP/E –Yield –
Radiopharm Theranostics Ltd financial ratios
See a number that looks wrong?